Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Starbucks To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Starbucks between November 2, 2023 and April 30,…
Month: September 2024
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lululemon
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Lululemon To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Lululemon between December 7, 2023 and July 24,…
Faruqi & Faruqi Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – OFIX
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Orthofix To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Orthofix between October 11, 2022, and September 12,…
Faruqi & Faruqi Reminds CrowdStrike Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – CRWD
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In CrowdStrike To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in CrowdStrike between November 29, 2023 and July…
IASO Bio Presented Comparative Clinical Outcomes on the Optimal Lymphodepletion Prior to Infution of Equecabtagene Autoleucel（FucasoTM）in Patients with Relapsed Refractory Multiple Myeloma at 2024 IMS Annual Meeting
SHANGHAI and NANJING, China and SAN JOSE, Calif, Sept. 29, 2024 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, today announced a poster…
SeromYx Systems and ACROBiosystems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies
NEWARK, Del., Sept. 29, 2024 /PRNewswire/ — SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, an innovative provider for life science solutions and tools, are excited to announce the release of their joint study on the comprehensive functional profiling…
Faruqi & Faruqi Reminds Arbor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – ABR
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Arbor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Arbor stock or options between May 7, 2021…
Faruqi & Faruqi Reminds Arbor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – ABR
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Arbor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Arbor stock or options between May 7, 2021…
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ford Motor Company
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Ford To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Ford between April 27, 2022 and July 24, 2024 and would…
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ford Motor Company
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Ford To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Ford between April 27, 2022 and July 24, 2024 and would…
